School of Medicine
Showing 1-10 of 10 Results
-
Robin Augustine
Basic Life Research Scientist, Rad/Pediatric Radiology
Current Role at StanfordDr. Robin Augustine's current research interests center on three captivating areas: graphene-based bioscaffolds, islet transplantation, and synchronized cellular response. In the realm of graphene-based bioscaffolds, Dr. Augustine actively explores graphene's potential as a biomaterial for tissue engineering. With its unique properties, graphene offers exceptional opportunities for developing innovative bioscaffolds. Dr. Augustine aims to design and engineer graphene-based materials that can provide structural support, promote cellular adhesion and growth, and enhance tissue regeneration. Leveraging the exceptional properties of graphene, such as its mechanical strength, electrical conductivity, and biocompatibility, Dr. Augustine's goal is to contribute to the development of advanced bioscaffolds for various applications in regenerative medicine. Another area of Dr. Augustine's research focuses on islet transplantation, particularly in treating diabetes. Islet transplantation holds promise as a potential cure for type 1 diabetes, involving the transfer of insulin-producing islet cells into the recipient's pancreas. Dr. Augustine investigates strategies to optimize islet transplantation techniques, improve the long-term viability of transplanted islets, and enhance their functionality. The ultimate objective is to contribute to the development of more effective and sustainable approaches for islet transplantation, with the aim of improving the quality of life for individuals living with diabetes. Dr. Augustine also explores the field of synchronized cellular response, recognizing its crucial role in tissue development, regeneration, and repair. The focus is on understanding and manipulating synchronized cellular response in complex tissue systems. By studying the intricate signaling pathways and cellular interactions, Dr. Augustine aims to identify key factors and mechanisms that regulate coordinated cellular behavior. This knowledge can inform the development of strategies to enhance tissue regeneration and repair processes, potentially leading to improved outcomes in various biomedical applications. Through research in graphene-based bioscaffolds, islet transplantation, and synchronized cellular response, Dr. Augustine strives to contribute to the advancement of tissue engineering, regenerative medicine, and the development of innovative therapies for complex medical challenges.
-
Parth Patel
Temp - Non-Exempt, Rad/Pediatric Radiology
Current Role at StanfordAs a Software Developer at Stanford University, I am contributing to the Biomedical Informatics Research and Translation (BIRAT) initiative, where I am involved in transformative healthcare technologies. My role involves mastering full stack web development, conducting detailed software testing, evaluation, and documentation. Additionally, I am honing my skills in managing large datasets, implementing artificial intelligence and deep learning solutions, and enhancing computational resources. This position has allowed me to advance my technical expertise while supporting innovative research in the radiology department, ensuring the development of robust and efficient software solutions that meet the team’s needs.
-
Rosita Primavera
Basic Life Research Scientist, Rad/Pediatric Radiology
BioDr. Rosita Primavera is a Basic Life Research Scientist at Stanford University in the Department of Radiology/Pediatric Radiology. She has a MD in chemistry and pharmaceutical technology and a PhD degree in Cellular and Molecular Biotechnologies. Dr. Primavera has documented experience on the development of nano- and micro-drug delivery systems (DDS) as well as 3D-platforms for the treatment of different diseases. She has trained in developing DDS and 3D-platforms with different materials (synthetic or natural) and employing different techniques (e.g. top/down or bottom/up fabrication). In the last few years, her research interests are focused primarily on diabetes. She has been extensively trained on how to handle and process pancreatic islets from different origins (mouse, rat and human) and she has excellent knowledge and skills to manage and perform in vitro and in vivo experiments involving diabetic animals. She is currently working on the realization of on-commanded system mimicking pancreatic islet function; and both the role of 3D-bioscaffold in pancreatic islet transplantation and the role of the mesenchymal stem cell in the setting of diabetes using novel cellular approaches (i.e. co-transplantation with islets alone or within novel bioscaffolds).
-
Raheleh Roudi
Basic Life Research Scientist, Rad/Pediatric Radiology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers.